Suppr超能文献

氩激光小梁成形术在无晶状体眼和人工晶状体眼中的疗效。

Efficacy of argon laser trabeculoplasty in aphakic and pseudophakic eyes.

作者信息

Schwartz A L, Wilson M C, Schwartz L W

机构信息

Department of Ophthalmology, Washington Hospital Center, Washington, DC, USA.

出版信息

Ophthalmic Surg Lasers. 1997 Mar;28(3):215-8.

PMID:9076795
Abstract

BACKGROUND AND OBJECTIVE

This study evaluated the efficacy of argon laser trabeculoplasty (ALT) in patients with aphakia or pseudophakia.

PATIENTS AND METHODS

The authors retrospectively analyzed 63 eyes of 63 patients with aphakia or pseudophakia who had uncontrolled open-angle glaucoma and were treated with 180 degrees or 360 degrees ALT.

RESULTS

The mean intraocular pressure (IOP) before ALT was 25.1 mm Hg (+/- 8.1 mm Hg). Two years after ALT, the mean IOP in the successfully treated group was 15.4 mm Hg. The mean survival time (50% success rate) for all treated eyes was 23 months, and treatment was successful in 34% of eyes at 36 months. Pseudophakic eyes had a better response than aphakic eyes (P = .06), and eyes that had extracapsular surgery did better than eyes with intracapsular surgery (P = .07).

CONCLUSION

ALT in aphakic or pseudophakic eyes with uncontrolled glaucoma is a safe, reasonably effective treatment that can delay the need for trabeculectomy.

摘要

背景与目的

本研究评估了氩激光小梁成形术(ALT)对无晶状体或人工晶状体眼患者的疗效。

患者与方法

作者回顾性分析了63例无晶状体或人工晶状体眼患者的63只眼睛,这些患者患有未控制的开角型青光眼,并接受了180度或360度的ALT治疗。

结果

ALT治疗前平均眼压(IOP)为25.1 mmHg(±8.1 mmHg)。ALT治疗两年后,成功治疗组的平均眼压为15.4 mmHg。所有治疗眼的平均生存时间(成功率50%)为23个月,36个月时34%的眼睛治疗成功。人工晶状体眼比无晶状体眼反应更好(P = 0.06),行囊外手术的眼睛比行囊内手术的眼睛效果更好(P = 0.07)。

结论

对患有未控制青光眼的无晶状体或人工晶状体眼进行ALT是一种安全、相当有效的治疗方法,可推迟小梁切除术的需要。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验